HSBC Mutual FundEquity Schemes - Small Cap Fund3.9 years
The Scheme will primarily be a diversified equity fund which will invest predominantly in small cap stocks to generate long term capital appreciation.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer Mahindra Manulife Small Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.9 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -27.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Mayank Chaturvedi · 1.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 20.6% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 27%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY SMALLCAP 250 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
11 Dec 2024 – 18 Aug 2026
Trough 3 Mar 2025 · recovered in 533 days
-27.2%
8 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-12.9%
7 Feb 2024 – 10 Apr 2024
Trough 13 Mar 2024 · recovered in 28 days
-11.0%
16 Oct 2024 – 6 Dec 2024
Trough 13 Nov 2024 · recovered in 23 days
-10.0%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
56
Vs category
n/a
Consistency
n/a
Risk-adjusted
57
Drawdown
32
Mean
48
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
30 Sept 2026 · 109 holdings · top 10 are 20.6%.
Apar Industries Ltd
Diversified
2.7%
Sai Life Sciences Ltd.
Healthcare
2.2%
Engineers India Ltd
Industrials
2.2%
Karur Vysya Bank Ltd
Financial
2.0%
Welspun India Ltd
Consumer Discretionary
2.0%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mahindra Manulife Mutual Fund
UTI Mutual Fund
Axis Mutual Fund
Caveat: Deeper drawdown
Mirae Asset Mutual Fund
Caveat: Lower trailing returns
ICICI Prudential Mutual Fund
Caveat: Deeper drawdown · Lower trailing returns
HSBC Mutual FundEquity Schemes - Small Cap Fund3.9 years
The Scheme will primarily be a diversified equity fund which will invest predominantly in small cap stocks to generate long term capital appreciation.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Prefer peers if · Prefer Mahindra Manulife Small Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.9 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -27.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Mayank Chaturvedi · 1.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 20.6% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 27%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
30 Oct 2026 · +2.3% over 1Y
93.2503
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY SMALLCAP 250 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-10.8%
11 Dec 2024 – 18 Aug 2026
Trough 3 Mar 2025 · recovered in 533 days
-27.2%
8 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-12.9%
7 Feb 2024 – 10 Apr 2024
Trough 13 Mar 2024 · recovered in 28 days
-11.0%
16 Oct 2024 – 6 Dec 2024
Trough 13 Nov 2024 · recovered in 23 days
-10.0%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
56
Vs category
n/a
Consistency
n/a
Risk-adjusted
57
Drawdown
32
Mean
48
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
30 Sept 2026 · 109 holdings · top 10 are 20.6%.
Apar Industries Ltd
Diversified
2.7%
Sai Life Sciences Ltd.
Healthcare
2.2%
Engineers India Ltd
Industrials
2.2%
Karur Vysya Bank Ltd
Financial
2.0%
Welspun India Ltd
Consumer Discretionary
2.0%